Christopher Davis, DO
Family Medicine · Greenville, SCNPI 1174056097
Payments from drug & device makers
Across 277 payments — averaging $9671.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1.1M
- Merck$664K
- Pfizer$524K
- Abbott$187K
- Amgen$95K
- Regeneron$47K
- plus $57K from 23 others
Across 6 payments — averaging $1622.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$8K
- Pfizer$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 25 | $1,105,941 |
| Merck | 18 | $664,035 |
| Pfizer | 63 | $523,920 |
| Abbott | 39 | $186,840 |
| Amgen | 4 | $94,655 |
| Regeneron | 32 | $46,797 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $28,342 |
| Sanofi Pasteur Inc. | 5 | $20,572 |
| GSK | 3 | $6,723 |
| Novo Nordisk | 24 | $345 |
| AbbVie | 23 | $297 |
| Dexcom, Inc. | 3 | $65 |
| Exact Sciences | 4 | $59 |
| Novartis | 3 | $56 |
| AstraZeneca(2 entities) | 3 | $52 |
| Inari Medical, Inc. | 2 | $48 |
| Bayer | 3 | $48 |
| Astellas Pharma US Inc | 2 | $46 |
| Cranial Technologies, Inc | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Tris Pharma Inc | 1 | $24 |
| Recor Medical Inc | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Lucid Diagnostics Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
| Corium, LLC | 1 | $14 |
| Organon | 1 | $13 |
How this compares
$2,679,077 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Greenville
- James FranklinGreenville$3.5M
- Jeffrey HarrisGreenville$3.4M
- Harlicia FarleyGreenville$1.1M
- James WallaceGreenville$708K
- Eric Garcia-TorresGreenville$102K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- Stephen GrubbLittle River$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.